| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Business Case Study - How Over Disclosure Hurt the Franchise Buyer the Laws are Trying to Protect |
|
Advice You - Business Case Study - How Over Disclosure Hurt the Franchise Buyer the Laws are Trying to Protect
There are often complaints that the regulatory bodies that monitor businesses in the Un According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ited States of America go way too far in justifying the creation of more rules and regu ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ations. Many consumers believe that the businesses are just trying to get away with som lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. thing and are complaining because it costs them extra money to comply. Indeed business here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s would rather have no regulations and yet we know that is probably not possible. Howe d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro er, we should consider that over disclosure in the franchising industry hurts the franc ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ise buyer or consumer, which is the very consumer the Federal Trade Commission of the U easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ited States of America is trying to protect. How does over disclosure hurt the consume nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ? Well, all the costs of regulation compliance must be passed on to the consumer at the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ time of the sale otherwise the company cannot stay in business and make a profit. Compa ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ies are not charity events and they must make a profit to stay in business otherwise th ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ere is no sense in them working hard to maintain their current operations. In franchis dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ng the Uniform Franchise Offering Circular for most franchising companies is well over cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin 50 pages. Due to the large volume of pages and with all the potential stipulations the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen franchise buyer is locked into a not so good deal. Since the franchise agreements and t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel isclosure documents are written by the franchisor's attorneys you can imagine that thes ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust legal documents are not good for the franchise buyer. Of course it is all legal and y y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products u can thank the Federal Trade Commission for hurting the consumer and costing them tens . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de of thousands of dollars on each franchise sale, which means the return on investment fo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip buying a franchise could be extended far off into the future. Please consider all this tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Powerful Partnership: Legal Marketing and Graphic Design Self-Esteem and the Entrepreneur
|